Tennessee Senate Bill SB0378

Tennessee 2023-2024 Regular Session

• Introduced: 1/24/23
• Engrossed: 4/18/23
• Enrolled: 4/24/23
• Passed: 5/11/23
• Chaptered: 5/24/23

Caption

AN ACT to amend Tennessee Code Annotated, Title 33; Title 38; Title 39, Chapter 15, Part 4; Title 39, Chapter 17; Title 43, Chapter 27; Title 53; Title 67 and Title 68, Chapter 7, relative to cannabis.

Impact

The bill will significantly impact Tennessee's cannabis laws, particularly by formalizing the sale of hemp-derived products and increasing regulatory oversight. By requiring licenses for businesses that manufacture or sell these products, the bill aims to create a more standardized and safe environment for consumers. It mandates comprehensive testing of products to verify their safety and cannabinoid concentration, enhancing public health measures and compliance with federal regulations. Furthermore, the tax revenues generated from the sale of these products are designated to support the state's regulatory framework, which could lead to better enforcement and oversight in the industry.

Summary

Senate Bill 378 aims to regulate the sale and distribution of products containing hemp-derived cannabinoids in Tennessee. This bill sets out to clarify the definition of hemp-derived cannabinoids, create licensing requirements for suppliers and retailers, and establish safety standards for the sale of these products. The act specifically addresses the concentration limits for cannabinoids and mandates the testing of products before they can be sold to ensure safety and compliance with labeling requirements. Additionally, it imposes a 6% retail sales tax on hemp-related products, with the generated revenue allocated to support its regulatory oversight.

Sentiment

The sentiment regarding SB 378 appears to be mixed but leans towards support from industry stakeholders and legislators promoting business regulation and safety. Proponents argue that the bill represents a step forward in controlling the burgeoning hemp market, thus ensuring consumer protection and fostering economic growth within the sector. However, there are concerns about the potential for overregulation and the implications of taxation on consumer pricing, particularly in relation to accessibility for lower-income populations. The debate highlights the ongoing balance between health safety and the growth of emerging markets within the state.

Contention

One of the notable points of contention surrounding SB 378 is the enforcement of age restrictions, specifically regarding the sale of cannabinoid products to individuals under the age of twenty-one. This issue raises concerns about access and exposure among youth, as well as the practicality of enforcement. The specified penalties for non-compliance with the regulations and the additional tax burden on retailers could also face opposition from small business owners who argue that such measures could inhibit market entry and economic viability. Additionally, the bill's requirements for extensive testing and the associated costs may pose challenges to producers and retailers operating with smaller profit margins.